04.07.2016 - Retina Implant AG Announces Change in Leadership
|Following 12 years of successful development at Retina Implant AG, Dr. Walter-G. Wrobel, CEO of the company, has announced his resignation by mutual consent.|
29.02.2016 - Retina Implant AG Secures €26 Million Round of Private Funding
|Funding will Support Expansion into New Centres and Reimbursement for Retina Implant AG's Implant |
16.11.2015 - Retina Implant AG's Latest Study Results Presented at the 2015 American Academy of Ophthalmology Annual Meeting
Majority of Blind Patients Gain Some Visual Function with the Alpha IMS Implant
11.03.2015 - Retina Implant's Founder Awarded the Saudi Ophthalmological Society Gold Medal Lecture Award
Professor Eberhart Zrenner Honored with the Gold Medal for his Presentation on the Artificial Vision Industry at Saudi Ophthalmology 2015 Conference.
22.10.2014 - Retina Implant AG Clinical Investigator Presents Global Trial Results at the 2014 American Academy of Ophthalmology Annual Meeting
Study Finds Visual Function Improves in Majority of Patients Implanted with the CE Marked Alpha IMS Subretinal Microchip
15.09.2014 - Retina Implant AG's International Clinical Results Presented for the First Time in Europe
Professor Eberhart Zrenner Leads Discussion of Alpha IMS Patient Results One Year Post Implantation at Europe's Largest Ophthalmology Conference
11.08.2014 - German Statutory Health Insurance Grants NUB Innovation Status to Retina Implant's Alpha IMS Microchip
Potentially Life-Changing Subretinal Implant Now Available at Six Leading Eye Clinics Across Germany
30.06.2014 - Retina Implant AG's Lead Investigator Presents Patient Results at Retina International's 18th World Annual Congress
Professor Eberhart Zrenner Discusses the Future of Artificial Vision at Premier International Ophthalmology Meeting
23.06.2014 - Professor Eberhart Zrenner Delivers Keynote Lecture at the RP Fighting Blindness Annual Conference
Retina Implant AG's Lead Clinical Trial Investigator Presents Patient Experiences with the Alpha IMS Subretinal Implant
11.06.2014 - Comment on Pixium Vision’s European Initial Public Offering
As a leader in the ophthalmology community, we wanted to personally reach out to make you aware of additional key information with regards to Pixium.
12.05.2014 - Retina Implant AG Clinical Trial Results Presented for the First Time at Leading French Ophthalmology Congress
CEO Walter-G Wrobel Shares Patient Results with Subretinal Implants at the 2014 French Society of Ophthalmology (SFO) Congress
07.04.2014 - Retina Implant AG Clinical Trial Results Presented at World Ophthalmology Congress 2014
Leading Ophthalmologists Provide an Update on Breakthroughs in Artificial Vision Research
18.11.2013 - Retina Implant AG Clinical Trial Results Presented at the 2013 American Academy of Ophthalmology Annual Meeting
Dr. Katarina Stingl Shares Work on CE Marked Subretinal Implant Technology During the Young Ophthalmologists Session
06.11.2013 - Retina Implant AG Celebrates 10 Years of Innovation on Its Quest to Restore Useful Vision to People with Retinitis Pigmentosa
Company's 10 Year Anniversary Coincides with Publication of an Article by Co-founder Eberhart Zrenner, M.D. in Leading Scientific Journal, Science Translational Medicine
03.07.2013 - Retina Implant AG's Alpha IMS Wins CE Mark
First Wireless Subretinal Device to Restore Useful Vision in Patients Blinded by Retinitis Pigmentosa
13.05.2013 - Retina Implant AG Principal Investigators Meet at ARVO 2013 Annual Meeting
Top Retinal Surgeons Discuss Results and Learnings from Second Human Clinical Trial
20.02.2013 - Retina Implant AG Announces the Publication of Study Results on its Alpha IMS Implant in Proceedings of the Royal Society B
First Publication of Retina Implant’s Second Human Trial Examining the Ability of its Wireless Microchip to Restore Functional Vision in Patients with Retinitis Pigmentosa
28.09.2012 - Retina Implant AG Presents Clinical Trial Update to Advisory Board
Board Members Encouraged and Impressed with Visual Results Achieved to Date
07.09.2012 - Retina Implant AG’s Lead Researcher to Present at Annual EURETINA Congress
Professor Eberhart Zrenner to present results from Retina Implant AG’s second human clinical trial
09.08.2012 - Retina Implant Patient nominated for Bravery Award
|Chris James, the first clinical trial patient in the UK to receive our subretinal implant, has been nominated for Optometry Today’s Optical Bravery Award 2012.
10.07.2012 - Retina Implant AG Researcher and Trial Patient to Present at International Retina Congress
Global Momentum Continues for Retina Implant AG's Second Human Clinical Trial
HAMBURG, Germany, July 10, 2012 /PRNewswire/ -- Retina Implant AG, the leading developer of subretinal implants for patients blinded by retinitis pigmentosa (RP), today announced that results from the Company's second human clinical trial will be presented at the Retina International World Congress
28.06.2012 - 17. Retina International World Congress
Retina Implant AG together with Okuvision GmbH at the 17. Retina International World Congress in Hamburg on 07/14/2012.
04.05.2012 - First Patient in Asia Regains Useful Sight After Receiving Retina Implant AG's Microchip
First of three patients to be implanted at the University of Hong Kong Eye Institute
REUTLINGEN, Germany & HONG KONG, May 03, 2012 (BUSINESS WIRE) -- Retina Implant AG ("Retina Implant"), a leading developer of subretinal implants for the visually
impaired, today announced that the first patient in China to be implanted with its microchip on February 13, 2012 at the University of Hong Kong Eye Institute has since regained useful sight.
01.06.2011 - Retina Implant AG Founder Honoures at Euretina
Retina Implant AG Founder Professor Eberhart Zrenner and Research Team Honoured at EURETINA.
17.03.2011 - Retina Implant AG Partners with Wills Eye Institute to Bring Artificial Vision Clinical Trials to the United States
|Retina Implant AG, a leading developer of subretinal implants for the visually impaired, today announced that they will partner with the Wills Eye Institute in Philadelphia as the lead U.S. clinical trial investigator site. This partnership marks the first time Retina Implant’s subretinal implant technology will be utilized in studies by patients who suffer from retinitis pigmentosa in North America. |
10.11.2010 - Over 350 press articles about our results in the Proceedings of the Royal Society B
Our results in the Proceedings of the Royal Society B brought more than 350 press articles, Movies and Newscasts all over the world.
04.11.2010 - Proceedings of the Royal Society publish article about Retina Implant
|Studies Published in Proceedings of the Royal Society B Validates Retina Implant AG’s Clinical Trial Results.|
22.10.2010 - Press release from AMD.org about the AAO
The macula degeneration partnership (AMD.org) wrote about the American Academy of Ophthalmology annual meeting.
20.10.2010 - Retina Implant presents clinical trial results
Retina implant presents clinical trial results at the American Academy of Ophthalmology annual meeting
12.10.2010 - Retina Implant AG opens a new manufacturing plant preparation in place for expected 2011 launch of subretinal implant technology for the Blind
Retina Implant AG today announced the opening of a new manufacturing plant to meet anticipated demand for their implants.
15.06.2010 - Vision Quest: Retinal Implants Deliver the Promise of Sight to Damaged Eyes”
Scientific American online, June 2010
Reporter Larry Greenemeier discusses Retina Implant, AG’s subretinal implant that is currently being evaluated to restore useful vision to the blind. The article highlights the success of Retina Implant's first clinical trial as well as the initiation of its second clinical trial across Europe.
06.06.2010 - Healthwise: Innovations in Opthamology
WTVI-TV, Charlotte, N.C., June 2010
Dr. David Greenman provides viewers with an overview of Retina Implant’s technology.
17.05.2010 - New Technology To Restore Vision
|FOX Headline Health, May 2010|
Dr. Zrenner talks about a new retina implant that is restoring vision to blind patients.